Voyager Therapeutics, Inc.

NASDAQ:VYGR

6.32 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 29.57819.51690.0614.6144.853150.48-41.08741.0860.7120.65828.0731.4821.3576.5016.537117.84328.68118.06732.67420.43346.0875.1972.0082.0942.5750.9426.3451.1481.1771.4642.3623.3083.724.834.9374.9374.8842.5760000
Cost of Revenue 1.3921.1961.3350.9451.0861.0750.8341.3411.2042.81214.0217.91419.50522.34621.99625.03929.42332.29436.55129.77725.3224.83116.91416.63216.50714.85313.32719.56115.314.07212.72310.30910.4848.7329.226.4816.4555.5232.962.3992.1071.432
Gross Profit 28.18618.3288.7263.6693.767149.405-41.92139.745-0.492-2.15414.053-16.432-18.148-15.845-15.45992.804-0.742-14.227-3.877-9.34420.767-19.634-14.906-14.538-13.932-13.911-6.982-18.413-14.123-12.608-10.361-7.001-6.764-3.902-4.283-1.544-1.571-2.947-2.96-2.399-2.107-1.432
Gross Profit Ratio 0.9530.9390.9850.7950.7760.9931.020.967-0.691-3.2740.501-11.088-13.374-2.437-2.3650.788-0.026-0.787-0.119-0.4570.451-3.778-7.423-6.943-5.41-14.768-1.1-16.039-11.999-8.612-4.387-2.116-1.818-0.808-0.868-0.313-0.322-1.1440000
Reseach & Development Expenses 33.0625.89624.42125.86321.98518.56814.55119.33712.52714.34914.0217.91419.50522.34621.99625.03929.42332.29436.55129.77728.57624.83116.91416.63216.50714.85313.32719.56115.314.07212.72310.30910.4848.7329.226.4816.4555.5232.962.3992.1071.432
General & Administrative Expenses 10.1518.60710.2428.2588.2949.0288.4627.3077.5527.6598.3518.71410.4379.7448.278.2778.23910.2069.8918.4638.3229.6598.2556.60911.7627.1825.3664.9424.5164.9143.4813.372.8543.5653.1572.4752.3961.8811.5361.2571.1231.553
Selling & Marketing Expenses 1.300000000000000000000000000000000000000000
SG&A 10.1518.60710.2428.2588.2949.0288.4627.3077.5527.6598.3518.71410.4379.7448.278.2778.23910.2069.8918.4638.3229.6598.2556.60911.7627.1825.3664.9424.5164.9143.4813.372.8543.5653.1572.4752.3961.8811.5361.2571.1231.553
Other Expenses 0.020000.00300.9532.6370.06100.006-0.112-1.5833.9217.7220.83-0.046-0.8081.1930.978-0.1330.9780.629-0.084-0.7170.3990.55-0.282-0.2970.395-0.477-0.099-0.15-0.1860.1570-0.001-9.7490000
Operating Expenses 43.21134.50334.66334.12130.27927.59623.01326.64420.07922.00822.37126.62829.94232.0930.26633.31637.66242.546.44238.2436.89834.4925.16923.24128.26922.03518.69324.50319.81618.98616.20413.67913.33812.29712.3778.9568.8517.4044.4963.6562.4631.618
Operating Income -15.025-16.18354.063-29.507-25.426122.884-24.56314.442-19.367-21.355.702-25.146-28.585-25.589-23.72984.527-8.981-24.433-13.768-17.8079.189-29.293-23.161-21.147-25.694-21.093-12.348-23.355-18.639-17.522-13.842-10.371-9.618-7.467-7.44-4.019-3.967-4.828-4.496-3.656-3.23-2.985
Operating Income Ratio -0.508-0.8290.6-6.395-5.2390.8170.5980.352-27.201-32.4470.203-16.968-21.065-3.936-3.630.717-0.313-1.352-0.421-0.8710.199-5.637-11.534-10.099-9.978-22.392-1.946-20.344-15.836-11.969-5.86-3.135-2.585-1.546-1.507-0.814-0.812-1.8740000
Total Other Income Expenses Net 4.9084.8673.1543.4290.0031.8640.9533.1820.280.0310.006-0.112-1.5833.9217.7220.83-0.046-0.8081.1930.978-0.1330.9780.629-0.084-0.7170.3990.55-0.282-0.2970.395-0.477-0.099-0.15-0.1860.1570.102-0.001-9.749-0.194-0.349-1.34-0.067
Income Before Tax -10.117-11.31657.217-26.078-22.149124.748-23.6117.624-19.087-21.3195.708-25.137-30.12-21.649-15.92685.611-8.681-24.263-12.575-15.00611.153-27.17-22.532-20.289-25.541-20.106-11.798-23.346-18.681-16.874-14.319-9.299-9.335-7.188-7.283-3.917-3.895-14.577-4.69-4.005-4.57-3.052
Income Before Tax Ratio -0.342-0.580.635-5.652-4.5640.8290.5750.429-26.808-32.40.203-16.962-22.196-3.33-2.4360.726-0.303-1.343-0.385-0.7340.242-5.228-11.221-9.689-9.919-21.344-1.859-20.336-15.872-11.526-6.062-2.811-2.509-1.488-1.475-0.793-0.798-5.6590000
Income Tax Expense 0.0240.0140.822-0.1770.0590.7040.016-0.545-0.219-0.031-1.482-0.121-0.048-0.019-0.081-0.254-0.346-0.978-0.758-1.823-2.097-1.145-0.579-0.9420.037-0.18-0.031-0.4850.195-0.2260.355-0.303-0.433-0.465-0.1640-0.0730000.2940.159
Net Income -10.141-11.3356.395-25.901-22.208124.044-23.62617.624-18.868-21.2885.709-25.137-30.12-21.649-15.92685.611-8.681-24.263-12.575-15.00611.153-27.17-22.532-20.289-25.541-19.926-11.767-23.346-18.876-16.648-14.674-8.996-9.335-7.188-7.283-3.917-3.895-14.577-4.69-4.005-4.864-3.211
Net Income Ratio -0.343-0.5810.626-5.614-4.5760.8240.5750.429-26.5-32.3530.203-16.962-22.196-3.33-2.4360.726-0.303-1.343-0.385-0.7340.242-5.228-11.221-9.689-9.919-21.153-1.855-20.336-16.037-11.372-6.213-2.719-2.509-1.488-1.475-0.793-0.798-5.6590000
EPS -0.18-0.21.28-0.59-0.513.05-0.610.46-0.49-0.560.15-0.67-0.8-0.58-0.432.3-0.23-0.66-0.34-0.410.3-0.81-0.7-0.63-0.8-0.63-0.4-0.89-0.73-0.65-0.57-0.35-0.37-0.29-0.29-0.15-0.26-0.99-1.22-0.27-8.09-6.93
EPS Diluted -0.18-0.21.25-0.59-0.512.94-0.610.45-0.49-0.560.15-0.67-0.8-0.58-0.432.27-0.23-0.66-0.34-0.410.29-0.81-0.7-0.63-0.8-0.63-0.4-0.89-0.73-0.65-0.57-0.35-0.37-0.29-0.29-0.15-0.26-0.99-1.22-0.27-8.09-6.93
EBITDA -13.633-14.98755.398-28.562-24.34122.884-24.56315.783-18.163-18.5385.702-23.922-27.4-24.315-22.74285.589-8.055-23.591-13.768-17.0929.865-28.677-23.161-20.581-25.178-20.637-12.348-22.922-18.23-17.205-13.842-10.211-9.466-7.331-7.44-3.859-3.822-4.697-4.385-3.593-3.223-2.982
EBITDA Ratio -0.461-0.7680.615-6.19-5.0150.8170.5980.384-25.51-28.1730.203-16.142-20.192-3.74-3.4790.726-0.281-1.306-0.421-0.8360.214-5.518-11.534-9.829-9.778-21.908-1.946-19.967-15.489-11.752-5.86-3.087-2.545-1.518-1.507-0.782-0.783-1.8230000